Skip to content

Discovery Platform

A Powerful Tech Stack for Validating Difficult Targets

Discover More

Therapeutic Candidates

Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline

Learn More

Latest News and Updates

Press Releases

See iBio's latest press releases
Recent Announcements

iBio in the News

Learn about iBio’s newest collaborations, data announcements, and more
Read More

Join us at PepTalk, January 16-19

Matthew Greving, PhD, VP, Platform Technology & Machine Learning presents “Enhancing Bispecific T Cell Engager Discovery, Potency, Safety, and Developability with Machine Learning and Mammalian Display”
Learn More

Corporate Presentation

Get the most up-to-date company information
View Here

Accelerating Drug Discovery Through AI and Machine Learning

For Investor inquiries, please visit our Investor Site

Visit Here